AAVantgarde Bio

We are very happy to announce that we are giving updates on our 2 leads programs (AAVB-081 for USH1B and AAVB-039 for Stargardt's) in two presentations at ARVO 2025 (May 4-8 Salt Lake City). We look forward to seeing you there! Please reach out! https://lnkd.in/dMcSSKU3

We're #hiring a new Contract Clinical Data Manager (Opthalmology) in London Area, United Kingdom. Apply today or share this post with your network.

We're #hiring a new Contract Data Engineer (Biotechnology) in London Area, United Kingdom. Apply today or share this post with your network.

We're #hiring a new Contract Biostatistician (Opthalmology) in London Area, United Kingdom. Apply today or share this post with your network.

We're #hiring a new Contract SAS Programmer (Gene Therapy - Ophthalmology) in London Area, United Kingdom. Apply today or share this post with your network.

We're #hiring a new CMC Project Manager in London, England. Apply today or share this post with your network.

We're #hiring a new Supply Chain Manager in London, England. Apply today or share this post with your network.

We're #hiring a new Senior/ Medical Director, Ophthalmology in London Area, United Kingdom. Apply today or share this post with your network.

Today is Rare Disease Day – a day to raise awareness and stand in solidarity with those living with rare conditions. At AAVantgarde, our mission is to bring hope to those affected by Usher Syndrome Type 1B and Stargardt Disease—two rare, inherited retinal diseases that profoundly impact vision and quality of life. While each condition is unique, the challenges faced by the rare disease community are shared: the need for greater research, faster innovation, and stronger support networks. We are committed to pushing the boundaries of science to develop transformative treatments for these underserved communities. But we can’t do it alone. Today, we recognize the patients, families, advocates, and researchers who inspire us every day. Your resilience fuels our work, and your stories remind us why innovation in rare disease matters. Let’s continue to shine a light on rare diseases—because no one should have to navigate them alone. #RareDiseaseDay #UsherSyndrome #StargardtDisease #HopeForRare

Today is Rare Disease Day – a day to raise awareness and stand in solidarity with those living with rare conditions. At AAVantgarde, our mission is to bring hope to those affected by Usher Syndrome Type 1B and Stargardt Disease—two rare, inherited retinal diseases that profoundly impact vision and quality of life. While each condition is unique, the challenges faced by the rare disease community are shared: the need for greater research, faster innovation, and stronger support networks. We are committed to pushing the boundaries of science to develop transformative treatments for these underserved communities. But we can’t do it alone. Today, we recognize the patients, families, advocates, and researchers who inspire us every day. Your resilience fuels our work, and your stories remind us why innovation in rare disease matters. Let’s continue to shine a light on rare diseases—because no one should have to navigate them alone. #RareDiseaseDay #UsherSyndrome #StargardtDisease #HopeForRare